23 October 2025
Unilever Trading Statement – Third Quarter 2025 Broad-based growth, on track for full year outlook Third Quarter 2025 Nine Months 2025 (unaudited) USG Turnover vs 2024…
SOFTCAT plc (‘Softcat’, the ‘Group’) Preliminary results for the year ended 31 July 2025 Another record performance, alongside investment in future growth Softcat plc…
21 October 2025
GSK’s Shingrix new prefilled syringe presentation receives positive CHMP opinion GSK plc (LSE/NYSE: GSK) today announced that the European Medicine Agency’s (EMA) Committee for Medicinal Products…
BHP Group Limited Operational review for the quarter ended 30 September 2025 Delivering operational and project excellence into a constructive commodity price environment “We’ve…
BUNZL Q3 TRADING STATEMENT IN-LINE WITH EXPECTATIONS; FY GUIDANCE UNCHANGED Bunzl plc, the specialist international distribution and services Group, today announces its trading statement…
20 October 2025
Hargreaves Services plc (“Hargreaves”, the “Company” or the “Group”) Sale of first tranche of Renewable Energy Land Assets completed Hargreaves Services plc (AIM: HSP), a diversified…
THE MERCANTILE INVESTMENT TRUST PLC HALF YEAR REPORT & FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED31ST JULY 2025 Legal Entity Identifier: 549300BGX3CJIHLP2H42 Information disclosed…
Tezspire approved in the US for chronic rhinosinusitis with nasal polyps Approval broadens indication for Tezspire to a second disease characterised by epithelial-driven inflammation AstraZeneca…